These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27638859)

  • 1. ATM Expression Predicts Veliparib and Irinotecan Sensitivity in Gastric Cancer by Mediating P53-Independent Regulation of Cell Cycle and Apoptosis.
    Subhash VV; Tan SH; Yeo MS; Yan FL; Peethala PC; Liem N; Krishnan V; Yong WP
    Mol Cancer Ther; 2016 Dec; 15(12):3087-3096. PubMed ID: 27638859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.
    Kubota E; Williamson CT; Ye R; Elegbede A; Peterson L; Lees-Miller SP; Bebb DG
    Cell Cycle; 2014; 13(13):2129-37. PubMed ID: 24841718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status.
    Magrini R; Bhonde MR; Hanski ML; Notter M; Scherübl H; Boland CR; Zeitz M; Hanski C
    Int J Cancer; 2002 Sep; 101(1):23-31. PubMed ID: 12209584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells.
    Min A; Im SA; Jang H; Kim S; Lee M; Kim DK; Yang Y; Kim HJ; Lee KH; Kim JW; Kim TY; Oh DY; Brown J; Lau A; O'Connor MJ; Bang YJ
    Mol Cancer Ther; 2017 Apr; 16(4):566-577. PubMed ID: 28138034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
    Wang Y; Yang L; Zhang J; Zhou M; Shen L; Deng W; Liang L; Hu R; Yang W; Yao Y; Zhang H; Zhang Z
    Int J Oncol; 2018 Oct; 53(4):1667-1680. PubMed ID: 30085332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.
    LaBonte MJ; Manegold PC; Wilson PM; Fazzone W; Louie SG; Lenz HJ; Ladner RD
    Int J Cancer; 2009 Dec; 125(12):2957-69. PubMed ID: 19536776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
    Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
    Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells.
    Ray S; Shyam S; Fraizer GC; Almasan A
    Mol Cancer Ther; 2007 Apr; 6(4):1368-78. PubMed ID: 17431115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
    Davidson D; Wang Y; Aloyz R; Panasci L
    Invest New Drugs; 2013 Apr; 31(2):461-8. PubMed ID: 23054213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the ATM gene occurs in gastric cancer cell lines and primary tumors associated with cellular response to DNA damage.
    Zhang L; Jia G; Li WM; Guo RF; Cui JT; Yang L; Lu YY
    Mutat Res; 2004 Jan; 557(1):41-51. PubMed ID: 14706517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
    Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
    Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of beta-carotene-induced apoptosis of gastric cancer cells: involvement of ataxia-telangiectasia-mutated.
    Jang SH; Lim JW; Kim H
    Ann N Y Acad Sci; 2009 Aug; 1171():156-62. PubMed ID: 19723050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.
    Sanmartín E; Muñoz L; Piqueras M; Sirerol JA; Berlanga P; Cañete A; Castel V; Font de Mora J
    Clin Cancer Res; 2017 Nov; 23(22):6875-6887. PubMed ID: 28830922
    [No Abstract]   [Full Text] [Related]  

  • 14. 2-Hydroxyethyl methacrylate-induced apoptosis through the ATM- and p53-dependent intrinsic mitochondrial pathway.
    Schweikl H; Petzel C; Bolay C; Hiller KA; Buchalla W; Krifka S
    Biomaterials; 2014 Mar; 35(9):2890-904. PubMed ID: 24411679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
    Xie H; Li C; Dang Q; Chang LS; Li L
    Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis.
    Cao Y; Jin ZX; Tong XP; Yue S; Sakai T; Kawanami T; Sawaki T; Miki M; Iwao H; Nakajima A; Masaki Y; Fukushima Y; Fujita Y; Nakajima H; Okazaki T; Umehara H
    Anticancer Res; 2010 Oct; 30(10):3911-7. PubMed ID: 21036702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.
    Huang SW; Chang SH; Mu SW; Jiang HY; Wang ST; Kao JK; Huang JL; Wu CY; Chen YJ; Shieh JJ
    J Dermatol Sci; 2016 Mar; 81(3):182-91. PubMed ID: 26775629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
    Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
    Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.
    Siu WY; Lau A; Arooz T; Chow JP; Ho HT; Poon RY
    Mol Cancer Ther; 2004 May; 3(5):621-32. PubMed ID: 15141020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
    Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.